Icare Home Tonometer: A Review of Characteristics and Clinical Utility

John Liu,1,2 Ticiana De Francesco,1,2 Matthew Schlenker,1,2 Iqbal Ike Ahmed1,2 1Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; 2Prism Eye Institute, Oakville, Ontario, CanadaCorrespondence: Iqbal Ike Ahmed Tel +1 (905) 456-3937Email ike.research@pri...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu J, De Francesco T, Schlenker M, Ahmed II
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	icare home icare self-tonometry glaucoma Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/f36c24bf34354480ad507a9f6ab25158
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f36c24bf34354480ad507a9f6ab25158
record_format	dspace
spelling	oai:doaj.org-article:f36c24bf34354480ad507a9f6ab251582021-12-02T11:07:14ZIcare Home Tonometer: A Review of Characteristics and Clinical Utility1177-5483https://doaj.org/article/f36c24bf34354480ad507a9f6ab251582020-11-01T00:00:00Zhttps://www.dovepress.com/icare-home-tonometer-a-review-of-characteristics-and-clinical-utility-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483John Liu,1,2 Ticiana De Francesco,1,2 Matthew Schlenker,1,2 Iqbal Ike Ahmed1,2 1Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; 2Prism Eye Institute, Oakville, Ontario, CanadaCorrespondence: Iqbal Ike Ahmed Tel +1 (905) 456-3937Email ike.research@prismeye.caAbstract: The Icare HOME (TA022, Icare Oy, Vanda, Finland) is rebound tonometer recently approved by the US Food and Drug Administration in March 2017 designed for self-measurement of intraocular pressure (IOP). IOP remains a major modifiable risk factor for glaucoma progression; however, IOP measurements typically occur through single office measurements on Goldmann applanation tonometry (GAT) and do not always reveal the complete picture of patient’s IOP patterns and daily fluctuations, which are important for accurate diagnosis and evaluation. Numerous studies have now compared the efficacy of the Icare HOME to that of GAT. The objective of this article is to review the existing literature surrounding the Icare HOME tonometer and its efficacy as a self-tonometer in comparison to GAT. The available literature has shown promising results in its accuracy of measuring IOP but suggests cautious usage in patients with central corneal thicknesses or IOP ranges that are outside of a certain range. This article will also provide details and example cases for when the Icare HOME may be most clinically useful.Keywords: Icare HOME, Icare, self-tonometry, glaucomaLiu JDe Francesco TSchlenker MAhmed IIDove Medical Pressarticleicare homeicareself-tonometryglaucomaOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 4031-4045 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	icare home icare self-tonometry glaucoma Ophthalmology RE1-994
spellingShingle	icare home icare self-tonometry glaucoma Ophthalmology RE1-994 Liu J De Francesco T Schlenker M Ahmed II Icare Home Tonometer: A Review of Characteristics and Clinical Utility
description	John Liu,1,2 Ticiana De Francesco,1,2 Matthew Schlenker,1,2 Iqbal Ike Ahmed1,2 1Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; 2Prism Eye Institute, Oakville, Ontario, CanadaCorrespondence: Iqbal Ike Ahmed Tel +1 (905) 456-3937Email ike.research@prismeye.caAbstract: The Icare HOME (TA022, Icare Oy, Vanda, Finland) is rebound tonometer recently approved by the US Food and Drug Administration in March 2017 designed for self-measurement of intraocular pressure (IOP). IOP remains a major modifiable risk factor for glaucoma progression; however, IOP measurements typically occur through single office measurements on Goldmann applanation tonometry (GAT) and do not always reveal the complete picture of patient’s IOP patterns and daily fluctuations, which are important for accurate diagnosis and evaluation. Numerous studies have now compared the efficacy of the Icare HOME to that of GAT. The objective of this article is to review the existing literature surrounding the Icare HOME tonometer and its efficacy as a self-tonometer in comparison to GAT. The available literature has shown promising results in its accuracy of measuring IOP but suggests cautious usage in patients with central corneal thicknesses or IOP ranges that are outside of a certain range. This article will also provide details and example cases for when the Icare HOME may be most clinically useful.Keywords: Icare HOME, Icare, self-tonometry, glaucoma
format	article
author	Liu J De Francesco T Schlenker M Ahmed II
author_facet	Liu J De Francesco T Schlenker M Ahmed II
author_sort	Liu J
title	Icare Home Tonometer: A Review of Characteristics and Clinical Utility
title_short	Icare Home Tonometer: A Review of Characteristics and Clinical Utility
title_full	Icare Home Tonometer: A Review of Characteristics and Clinical Utility
title_fullStr	Icare Home Tonometer: A Review of Characteristics and Clinical Utility
title_full_unstemmed	Icare Home Tonometer: A Review of Characteristics and Clinical Utility
title_sort	icare home tonometer: a review of characteristics and clinical utility
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/f36c24bf34354480ad507a9f6ab25158
work_keys_str_mv	AT liuj icarehometonometerareviewofcharacteristicsandclinicalutility AT defrancescot icarehometonometerareviewofcharacteristicsandclinicalutility AT schlenkerm icarehometonometerareviewofcharacteristicsandclinicalutility AT ahmedii icarehometonometerareviewofcharacteristicsandclinicalutility
_version_	1718396268607176704

Icare Home Tonometer: A Review of Characteristics and Clinical Utility

Ejemplares similares